Advertisement

Sodium Acetate Injection

[07 May 2014]

Products Affected - Description

Sodium acetate, American Regent
2 mEq/mL, 20 mL vial (NDC 00517-2096-25)
4 mEq/mL, 50 mL vial (NDC 00517-5023-25)
2 mEq/mL, 100 mL vial (NDC 00517-2500-25) - discontinued

Reason for the Shortage

  • American Regent had temporarily suspended distribution of most drug products including all sodium acetate presentations in April, 2011.
  • American Regent resumed manufacturing in Shirley, New York in early-May, 2011.
  • American Regent has discontinued sodium acetate 2 mEq/mL 100 mL vials. 
  • Fresenius Kabi (formerly APP) had sodium acetate on shortage due to increased demand.
  • Hospira had sodium acetate on shortage due to manufacturing delays.
  • Baxter discontinued sodium acetate in June, 2008.

Available Products

Sodium acetate, Fresenius Kabi (formerly APP)
4 mEq/mL, 100 mL vial (NDC 63323-0032-61)
 
Sodium acetate, Hospira
2 mEq/mL, 20 mL vial (NDC 00409-7299-73) 
2mEq/mL, 50 mL vial (NDC 00409-3299-05)
2mEq/mL, 100 mL vial (NDC 00409-3299-06)
 

Estimated Resupply Dates

American Regent has all sodium acetate presentations on back order and the company cannot estimate a release date.

Related Shortages

Updated

May 7, 2014; February 10, 2014; November 6, 2013; September 18, 2013; July 25, 2013; May 23, 2013; April 1, 2013; March 11, 2013; March 1, 2013; January 30, 2013; January 4, 2013; December 24, 2012; November 6, 2012; October 9, 2012; October 4, 2012; September 12, 2012; August 22, 2012; July 31, 2012; July 3, 2012; June 18, 2012; May 22, 2012; May 2, 2012; April 25, 2012; April 17, 2012; March 29, 2012; March 12, 2012; February 15, 2012; February 1, 2012; January 5, 2012; December 13, 2011; November 23, 2011; November 2, 2011; October 31, 2011; October 20, 2011; September 29, 2011; August 30, 2011; August 17, 2011; August 8, 2011; August 4, 2011; July 22, 2011; June 16, 2011; June 1, 2011; April 29, 2011; April 18, 2011; April 8, 2011, University of Utah, Drug Information Service. Copyright 2014, Drug Information Service, University of Utah, Salt Lake City, UT.

Disclaimer

This information is provided through the support of Novation to ASHP solely as a service to its members, which shall not use this information for their further commercial use. The content was prepared by the Drug Information Center of University of Utah. Novation, ASHP, and the University of Utah make no representations or warranties, express or implied, including, but not limited to, any implied warranty of merchantability and/or fitness for a particular purpose, which respect to such information, and specifically disclaim all such warranties. Users of this information are advised that decisions regarding the use of drugs and drug therapies are complex medical decisions and that in using this information, each user must exercise his or her own independent professional judgment. Neither Novation, ASHP nor the University of Utah assumes any liability for persons administering or receiving drugs or other medical care in reliance upon this information, or otherwise in connection with this bulletin. Neither Novation, ASHP nor University of Utah endorses or recommends the use of any drug.

« Back to Drug Shortage Product Bulletins

Advocacy Activity
Get the latest updates on ASHP's advocacy activity on drug shortages.
Advertisement